ATE404163T1 - Verwendung von beta-carotin und lycopin zur behandlung des hautalterns durch inhibierung der auswirkung der metalloproteinase des typs 1 der extrazellularen matrix - Google Patents
Verwendung von beta-carotin und lycopin zur behandlung des hautalterns durch inhibierung der auswirkung der metalloproteinase des typs 1 der extrazellularen matrixInfo
- Publication number
- ATE404163T1 ATE404163T1 AT01982552T AT01982552T ATE404163T1 AT E404163 T1 ATE404163 T1 AT E404163T1 AT 01982552 T AT01982552 T AT 01982552T AT 01982552 T AT01982552 T AT 01982552T AT E404163 T1 ATE404163 T1 AT E404163T1
- Authority
- AT
- Austria
- Prior art keywords
- inhibiting
- skin aging
- lycopine
- metalloproteinase
- carotene
- Prior art date
Links
- 230000000694 effects Effects 0.000 title abstract 4
- 235000013734 beta-carotene Nutrition 0.000 title abstract 3
- 239000011648 beta-carotene Substances 0.000 title abstract 3
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 title abstract 3
- 230000002401 inhibitory effect Effects 0.000 title abstract 2
- 230000009759 skin aging Effects 0.000 title abstract 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 title 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 title 1
- 102000005741 Metalloproteases Human genes 0.000 title 1
- 108010006035 Metalloproteases Proteins 0.000 title 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 title 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 title 1
- 229960002747 betacarotene Drugs 0.000 title 1
- 210000002744 extracellular matrix Anatomy 0.000 title 1
- 235000021466 carotenoid Nutrition 0.000 abstract 2
- 150000001747 carotenoids Chemical class 0.000 abstract 2
- 102000008186 Collagen Human genes 0.000 abstract 1
- 108010035532 Collagen Proteins 0.000 abstract 1
- 102000029816 Collagenase Human genes 0.000 abstract 1
- 108060005980 Collagenase Proteins 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 229920001436 collagen Polymers 0.000 abstract 1
- 210000004400 mucous membrane Anatomy 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0013753A FR2815859B1 (fr) | 2000-10-26 | 2000-10-26 | Utilisation de l'association d'au moins un carotenoide a activite provitaminique a et d'au moins un carotenoide sans activite provitaminique a pour traiter les signes du vieillissement |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE404163T1 true ATE404163T1 (de) | 2008-08-15 |
Family
ID=8855769
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01982552T ATE404163T1 (de) | 2000-10-26 | 2001-10-25 | Verwendung von beta-carotin und lycopin zur behandlung des hautalterns durch inhibierung der auswirkung der metalloproteinase des typs 1 der extrazellularen matrix |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20040071744A1 (de) |
| EP (1) | EP1331924B1 (de) |
| JP (2) | JP2004512294A (de) |
| AT (1) | ATE404163T1 (de) |
| AU (1) | AU2002214102A1 (de) |
| DE (1) | DE60135364D1 (de) |
| ES (1) | ES2312480T3 (de) |
| FR (1) | FR2815859B1 (de) |
| WO (1) | WO2002034232A2 (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2829388B1 (fr) * | 2001-09-11 | 2005-09-02 | Oreal | Utilisation d'au moins un carotenoide dans une composition cosmetique |
| US20070031356A1 (en) * | 2005-07-01 | 2007-02-08 | Petra Buchwald Hunziker | Beta-carotene modulation of gene expression |
| EA015246B1 (ru) | 2006-02-21 | 2011-06-30 | Мэри Кэй, Инк. | Неводная композиция стабильной аскорбиновой кислоты и способ ее приготовления |
| CN102015030A (zh) * | 2006-03-31 | 2011-04-13 | 帝斯曼知识产权资产管理有限公司 | 化合物和化合物的组合用于改善身体外观的新型用途 |
| EP2004161B8 (de) * | 2006-04-12 | 2013-04-17 | Unilever PLC | Orale zusammensetzung mit dha und genistein zur verbesserung der hauteigenschaften |
| EP2004169B1 (de) | 2006-04-12 | 2012-08-08 | Unilever PLC | Orale zusammensetzung mit einer mehrfach ungesättigten fettsäure und salicylsäure zur erzielung einer entzündungshemmenden wirkung in der haut |
| EP2004160B1 (de) * | 2006-04-12 | 2012-09-19 | Unilever PLC | Orale zusammensetzung mit anti-alterungswirkung für die haut |
| US20090162306A1 (en) * | 2007-12-21 | 2009-06-25 | Conopco, Inc., D/B/A Unilever | Topical composition comprising coloring antioxidants |
| EP2130833A1 (de) * | 2008-06-05 | 2009-12-09 | DSM IP Assets B.V. | Verfahren zur Herstellung von Zeacarotinen |
| EP2676553B1 (de) | 2011-02-18 | 2017-04-12 | FUJIFILM Corporation | Carotinoidhaltige zusammensetzung |
| FR2974300B1 (fr) | 2011-04-19 | 2013-05-10 | Inneov Lab | Utilisation d'une combinaison d'un carotenoide, d'un phytoestrogene et de la vitamine c pour la prevention et/ou le traitement de desordres pigmentaires |
| FR2974296B1 (fr) | 2011-04-19 | 2013-05-24 | Inneov Lab | Utilisation d'une combinaison d'un carotenoide, d'un phytoestrogene et de la vitamine c en tant qu'actif pour l'hydratation de la peau |
| MX2022000877A (es) * | 2019-07-24 | 2022-02-11 | Histocell Sl | Nueva composicion antioxidante para cicatrizacion de heridas. |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH552388A (de) * | 1970-07-10 | 1974-08-15 | Hoffmann La Roche | Lichtschutzmittel. |
| FR2727018B1 (fr) * | 1994-11-17 | 1997-01-31 | Jcb Cosmetiques | Composition orale pour la prevention des allergies solaires a base d'un carotenoide, d'un tocopherol, d'acide ascorbique et de selenium |
| DE4444238A1 (de) * | 1994-12-13 | 1996-06-20 | Beiersdorf Ag | Kosmetische oder dermatologische Wirkstoffkombinationen aus Zimtsäurederivaten und Flavonglycosiden |
| FR2749758B1 (fr) * | 1996-06-12 | 1998-08-07 | Oenobiol Sa Lab | Composition a activite bronzante et photoprotectrice et ses applications esthetiques |
| US5895652A (en) * | 1996-07-29 | 1999-04-20 | Longevity Institute International | Method of metabolic adjuvanation and cellular repair |
| US5976568A (en) * | 1997-02-21 | 1999-11-02 | Medical Doctors' Research Institute, Inc. | Modular system of dietary supplement compositions for optimizing health benefits and methods |
| TWI234467B (en) * | 1997-06-04 | 2005-06-21 | Univ Michigan | Composition for inhibiting photoaging of skin |
| US6048846A (en) * | 1998-02-26 | 2000-04-11 | Cochran; Timothy M. | Compositions used in human treatment |
| AT407821B (de) * | 1998-03-24 | 2001-06-25 | Franz Dr Stueckler | Mittel auf der basis von naturstoffen |
| DE19838636A1 (de) * | 1998-08-26 | 2000-03-02 | Basf Ag | Carotinoid-Formulierungen, enthaltend ein Gemisch aus beta-Carotin, Lycopin und Lutein |
| US20050031557A1 (en) * | 1999-09-08 | 2005-02-10 | Christine Gaertner | Oral administration of beta-carotene, lycopene and lutein for human skin protection |
| DE19942774A1 (de) * | 1999-09-08 | 2001-03-15 | Cognis Deutschland Gmbh | Zubereitungen zur oralen Aufnahme |
| FR2799370B1 (fr) * | 1999-10-07 | 2005-08-19 | Oreal | Utilisation du lycopene dans des compositions destinees a traiter les signes cutanes du vieillissement |
| WO2001026668A1 (en) * | 1999-10-14 | 2001-04-19 | Unilever N.V. | Compositions with anti-prostate cancer activity |
-
2000
- 2000-10-26 FR FR0013753A patent/FR2815859B1/fr not_active Expired - Fee Related
-
2001
- 2001-10-25 DE DE60135364T patent/DE60135364D1/de not_active Expired - Lifetime
- 2001-10-25 EP EP01982552A patent/EP1331924B1/de not_active Expired - Lifetime
- 2001-10-25 ES ES01982552T patent/ES2312480T3/es not_active Expired - Lifetime
- 2001-10-25 AT AT01982552T patent/ATE404163T1/de not_active IP Right Cessation
- 2001-10-25 WO PCT/FR2001/003315 patent/WO2002034232A2/fr not_active Ceased
- 2001-10-25 AU AU2002214102A patent/AU2002214102A1/en not_active Abandoned
- 2001-10-25 JP JP2002537286A patent/JP2004512294A/ja not_active Withdrawn
-
2003
- 2003-04-28 US US10/423,921 patent/US20040071744A1/en not_active Abandoned
-
2007
- 2007-11-30 JP JP2007309834A patent/JP2008156349A/ja not_active Withdrawn
-
2008
- 2008-10-03 US US12/245,223 patent/US20090227688A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2004512294A (ja) | 2004-04-22 |
| US20040071744A1 (en) | 2004-04-15 |
| AU2002214102A1 (en) | 2002-05-06 |
| US20090227688A1 (en) | 2009-09-10 |
| ES2312480T3 (es) | 2009-03-01 |
| WO2002034232A2 (fr) | 2002-05-02 |
| EP1331924B1 (de) | 2008-08-13 |
| FR2815859A1 (fr) | 2002-05-03 |
| FR2815859B1 (fr) | 2003-02-28 |
| WO2002034232A3 (fr) | 2002-06-27 |
| EP1331924A2 (de) | 2003-08-06 |
| JP2008156349A (ja) | 2008-07-10 |
| DE60135364D1 (de) | 2008-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE404163T1 (de) | Verwendung von beta-carotin und lycopin zur behandlung des hautalterns durch inhibierung der auswirkung der metalloproteinase des typs 1 der extrazellularen matrix | |
| ATE530179T1 (de) | Verwendung von kreatin und/oder kreatinderivaten in dermatologischen zubereitungen | |
| DE60115000D1 (de) | Die Verwendung von Prostaglandin F Analoga zur Herstellung von Zusammensetzungen für die Behandlung von Haarausfall. | |
| ATE257013T1 (de) | Verwendung von botulinum-toxin zur behandlung von diabetes | |
| ATE371475T1 (de) | Methoden zur behandlung der hautpigmentierung | |
| DE69428791D1 (de) | Verwendung vonModafinil zur Behandlung von Atemstillstand im Schlaf und zentral erregten Atembeschwerden | |
| ATE241358T1 (de) | Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen | |
| ATE473753T1 (de) | Verwendung von botulinum toxin zur behandlung von post-operative schmerzen | |
| ATE279181T1 (de) | Verwendung von 5ht-6 antagonisten zur behandlung adhd | |
| BR0109188A (pt) | Diarilaminas 5-amida substituìdas como inibidores de mex | |
| ATE279921T1 (de) | Verwendung von antikonvulsiven derivaten zur behandlung der cluster headache | |
| DE60115869D1 (de) | Zusammenseztungen und verfahren zur behandlung von haarausfall unter verwendung von c16-c20 aromatischen tetrahydro-prostaglandinen | |
| ATE281075T1 (de) | Zusammensetzung zum inaktivieren von reizstoffen in flüssigkeiten | |
| DE59205037D1 (de) | Vorrichtung zur behandlung von entzündlichen, sich im anfangsstadium befindlichen hautveränderungen | |
| ATE230591T1 (de) | Verwendung von ellagsäure und ihren derivaten in der kosmetik und der dermatologie | |
| DE69425287D1 (de) | N-hydroxypiperidine als superoxid-radikalfänger | |
| DE69527052D1 (de) | Verwendung von Wasser mit verringertem Deuterium-Gehalt zur Herstellung von hygienischen und kosmetischen Präparaten | |
| ATE278384T1 (de) | Zusammensetzung, insbensodere für kosmetika, enthaltend dhea und/oder einen chemische oder biologische vorläufer davon und einen metalloproteinase inhibitor | |
| DE60216281D1 (de) | Die verwendung von tyrosinkinasehemmer zur behandlung von allergischen erkrankungen | |
| DE69934410D1 (de) | Behandlung von akne und photobedingter alterung durch topische kurzzeitbehandlung mit retinoiden | |
| ATE353667T1 (de) | Verwendung von proteasom-inhibitoren zur behandlung des trockenen auges | |
| ATE402699T1 (de) | Verwendung von substituierten pyrazolen zur behandlung von allergien | |
| ATE222101T1 (de) | Verwendung von selegilin oder desmethylselegilin zur behandlung von wunden, verbrennungen und hautschäden | |
| DE59813914D1 (de) | Mittel zur behandlung und/oder prophylaxe von mikrozirkulationsstörungen | |
| WO2002034210A3 (fr) | Utilisation de l'association d'au moins un carotenoide et de vitamine c pour traiter les signes cutanes du vieillissement |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |